CClinicalTrials.gg
Active, not recruitingNCT04600583Updated Jul 23, 2024

A Trial of Mechanical Axis With Soft Tissue Release Balancing vs Functional Alignment With Bony Release Balancing in Total Knee Replacement Using Stryker's Mako Robot

An interventional study of Triathlon® Total Knee System (Stryker Orthopaedics, Mahwah, NJ USA) in Osteoarthritis, sponsored by Stryker South Pacific. Active, not recruiting at 1 site in New Zealand. Open to participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-07-23.

Sponsored by Stryker South Pacific · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
278
Allocation
Randomized
Ages
40 Years to 80 Years
Sex
All
01

Study summary

This study is a prospective, randomized, longitudinal study of the clinical outcomes of osteoarthritis patients treated by two different alignment philosophies for total knee replacement. All patients will be treated with the same knee system, implanted using MAKO robotic-arm assisted technology.

02

Conditions studied

  • Osteoarthritis

Browse trials for

Keywords

  • Knee
  • Arthroplasty
03

In context

Osteoarthritis

4,399 studies on the registry are indexed under Osteoarthritis; 583 are open to participants now.

This study's enrollment of 278 is above the median of 70 across 3,440 interventional studies indexed under Osteoarthritis.

Browse Osteoarthritis studies →

Lead sponsor

Stryker South Pacific is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • The patient is a male or non-pregnant female between the ages of 40-80 years.
  • The patient requires a primary total knee replacement and is indicated for robotic-assisted surgery.
  • Patient is deemed appropriate for a cruciate retaining knee replacement.
  • The patient has a primary diagnosis of osteoarthritis (OA).
  • The patient has intact collateral ligaments.
  • The patient is able to undergo CT scanning of the affected limb.
  • The patient has signed the study specific, ethics-approved, Informed Consent document.
  • The patient is willing and able to comply with the specified pre-operative and post-operative clinical and radiographic evaluations.

Exclusion criteria

Exclusion Criteria:

  • The patient has a history of total, unicompartmental reconstruction or fusion of the affected joint.
  • Patient has had a previous osteotomy around the knee.
  • The patient is morbidly obese (BMI ≥ 40).
  • The patient has a deformity which will require the use of stems, wedges or augments in conjunction with the Triathlon Total Knee System.
  • The patient has a varus/valgus deformity ≥ 15°.
  • The patient has a fixed flexion deformity ≥ 15°.
  • The patient has a neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device.
  • The patient has a systemic or metabolic disorder leading to progressive bone deterioration.
  • The patient is immunologically suppressed or receiving steroids in excess of normal physiological requirements.
  • Patient has a cognitive impairment, an intellectual disability or a mental illness.
  • The patient is pregnant.
  • The patient has metal hardware present in the region of the hip, knee or ankle (as this is known to create geometrical distortion in the region of the implant).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
278 participants (actual)

Study arms

  • Active comparator
    Alignment according to Functional Alignment philosophy

    Patients randomized to this group will undergo a TKA (total knee arthroplasty) to receive a Triathlon Total Knee System aligned according to Functional Alignment philosophy. This method of implant alignment is defined by a patient's native joint line as well as the soft tissue envelope. Triathlon Total Knee System components will be positioned relative to intra-operative soft tissue laxity assessment. A mobile application (KneeBalancer) will be used to assist surgeon decision making during the dynamic joint balancing surgical step.

    Device: Triathlon® Total Knee System (Stryker Orthopaedics, Mahwah, NJ USA)

  • Active comparator
    Alignment to the patient's natural Mechanical axis

    Patients randomized to this group will undergo a TKA (total knee arthroplasty) to receive a Triathlon Total Knee System neutrally aligned to the Mechanical axis. More specifically, the femoral component and tibial component are aligned 0° to the mechanical axis of each respective limb. Femoral component rotation is fixed to the trans-epicondylar axis. Soft tissue releases are performed at the discretion of the surgeon to achieve balance and full range of motion.

    Device: Triathlon® Total Knee System (Stryker Orthopaedics, Mahwah, NJ USA)

Interventions

  • DeviceTriathlon® Total Knee System (Stryker Orthopaedics, Mahwah, NJ USA)

    All patients, regardless of the alignment arm they are randomized to will undergo a primary total knee arthroplasty with the Triathlon® Total Knee System using Mako Robotic-Arm Assisted Technology. The surgical intervention will be administered by a physician wherein the expected duration of surgery is approximately 1.5 hours.

06

What researchers measure

Primary outcomes

  1. Joint feeling and Forgotten Joint Score

    To evaluate differences in joint feeling assessed via the Forgotten Joint Score. This newly-developed 12-item score ranges from 0 to 100 and assesses how aware recipients are of their joint in everyday life. Higher scores indicate a good outcome i.e. a high degree of forgetting the joint. For the purpose of this study a change in score of 14 points for the Forgotten Joint Score has been identified.

    Time frame: Pre-operative (2 weeks prior to surgery), Post-operative - 6 weeks, 6 months, 12 months (primary timepoint) and 24 months

Secondary outcomes

  1. Function and Oxford Knee Score

    To evaluate differences in function between Robotic Assisted Functional Alignment and Robotic Assisted Mechanical Alignment. This will be achieved by employing the following instrument: Oxford Knee Score. This score ranges from 0 to 48 where a higher score indicates a better outcome.

    Time frame: Pre-operative (2 weeks prior to surgery), Post-operative - 6 weeks, 6 months, 12 months and 24 months

  2. Function and The International Knee Society Score

    To evaluate differences in function between Robotic Assisted Functional Alignment and Robotic Assisted Mechanical Alignment. This will be achieved by employing the following instrument: The International Knee Society Score. This score ranges from 0 to 100 where a higher score correlates to a better outcome.

    Time frame: Pre-operative (2 weeks prior to surgery), Post-operative - 6 weeks, 12 months and 24 months

  3. Function and Knee Injury and Osteoarthritis Outcome Score

    To evaluate differences in function between Robotic Assisted Functional Alignment and Robotic Assisted Mechanical Alignment. This will be achieved by employing the following instrument: Knee Injury and Osteoarthritis Outcome Score. This score ranges from 0 to 100 where 0 indicates the worst possible knee symptoms and 100 signifies no knee symptoms.

    Time frame: Pre-operative (2 weeks prior to surgery), Post-operative - 6 weeks, 6 months, 12 months and 24 months

  4. Pain and Oxford Knee Score

    To evaluate differences in pain between Robotic Assisted Functional Alignment and Robotic Assisted Mechanical Alignment. This will be achieved by employing the following instrument: Oxford Knee Score. This score ranges from 0 to 48 where a higher score indicates a better outcome.

    Time frame: Pre-operative (2 weeks prior to surgery), Post-operative - 6 weeks, 6 months, 12 months and 24 months

  5. Pain and The International Knee Society Score

    To evaluate differences in pain between Robotic Assisted Functional Alignment and Robotic Assisted Mechanical Alignment. This will be achieved by employing the following instrument: The International Knee Society Score. This score ranges from 0 to 100 where a higher score correlates to a better outcome.

    Time frame: Pre-operative (2 weeks prior to surgery), Post-operative - 6 weeks, 12 months and 24 months

  6. Pain and Knee Injury and Osteoarthritis Outcome Score

    To evaluate differences in pain between Robotic Assisted Functional Alignment and Robotic Assisted Mechanical Alignment. This will be achieved by employing the following instrument: Knee Injury and Osteoarthritis Outcome Score. This score ranges from 0 to 100 where 0 indicates the worst possible knee symptoms and 100 signifies no knee symptoms.

    Time frame: Pre-operative (2 weeks prior to surgery), Post-operative - 6 weeks, 6 months, 12 months and 24 months

  7. Pain and Visual Analogue Scale

    To evaluate differences in pain between Robotic Assisted Functional Alignment and Robotic Assisted Mechanical Alignment. This will be achieved by employing the following graphic measurement instrument: Visual Analogue Scale. This scale is a continuum between no pain and the worst possible pain imaginable.

    Time frame: Pre-operative (2 weeks prior to surgery), Post-operative - 6 weeks, 6 months, 12 months and 24 months

  8. Satisfaction and Net Promoter Score

    To evaluate differences in satisfaction between Robotic Assisted Functional Alignment and Robotic Assisted Mechanical Alignment. This will be achieved by employing the following instrument: Net Promoter. This score ranges from -100 to 100 where the upper end indicates the patient's recommendation of the healthcare they received.

    Time frame: Pre-operative (2 weeks prior to surgery), Post-operative - 6 weeks, 6 months, 12 months and 24 months

  9. Health related quality of life and Euro-Qol (EQ-5D-3L)

    To evaluate differences in health-related quality of life between Robotic Assisted Functional Alignment and Robotic Assisted Mechanical Alignment. This will be achieved by employing the following instrument: Euro-Qol (EQ-5D-3L). This score ranges from 0 to 100 where 0 correlates to the worst imaginable health state whilst 100 indicates the best.

    Time frame: Pre-operative (2 weeks prior to surgery), Post-operative - 6 weeks, 6 months, 12 months and 24 months

  10. Early pain

    To evaluate differences in early pain (i.e. from in-patient setting to 6-months post operation) between Robotic Assisted Functional Alignment and Robotic Assisted Mechanical Alignment. This objective will be achieved through the use of a patient pain inventory form.

    Time frame: In-patient setting (< 5 days post-operation), Post-operative - 6 weeks and 6 months

  11. Early function

    To evaluate differences in early function between Robotic Assisted Functional Alignment and Robotic Assisted Mechanical Alignment. This objective will be achieved by utilizing functional tests conducted by physiotherapists. The following functional test will be carried out on the knee joint: Range of motion

    Time frame: In-patient setting (< 5 days post-operation)

  12. Early function

    To evaluate differences in early function between Robotic Assisted Functional Alignment and Robotic Assisted Mechanical Alignment. This objective will be achieved by utilizing functional tests conducted by physiotherapists. The following functional test will be employed: 9 step stair climb

    Time frame: In-patient setting (< 5 days post-operation)

  13. Early function

    To evaluate differences in early function between Robotic Assisted Functional Alignment and Robotic Assisted Mechanical Alignment. This objective will be achieved by utilizing functional tests conducted by physiotherapists. The following functional test will be employed: fast paced 10m walk test

    Time frame: In-patient setting (< 5 days post-operation)

  14. Early function

    To evaluate differences in early function between Robotic Assisted Functional Alignment and Robotic Assisted Mechanical Alignment. This objective will be achieved by utilizing functional tests conducted by physiotherapists. The following functional test will be employed: 30 second chair stand test

    Time frame: In-patient setting (< 5 days post-operation)

  15. Blood loss

    To compare blood loss between Robotic Assisted Functional Alignment and Robotic Assisted Mechanical Alignment. This objective will be achieved through obtaining surgical data.

    Time frame: Intra-operative

  16. Adjustments to balance

    To compare adjustments to balance between Robotic Assisted Functional Alignment and Robotic Assisted Mechanical Alignment. This objective will be achieved through obtaining the position from the Robotic system.

    Time frame: Intra-operative

  17. Ability to reach target knee balance as assessed by alignment angles and gaps

    To compare the ability to achieve soft tissue balance between Robotic Assisted Functional Alignment and Robotic Assisted Mechanical Alignment. This object will be achieved by comparing pre-operative plan and pre-resection gaps with the final surgical plan and implanted gaps as derived from the robotic system. The implant position is defined as the angulation of components and resected bone in each anatomical plane. The soft tissue balance is defined as gaps created in extension and 90° of flexion when stressing the medial compartment (medial collateral ligament) and lateral compartment (lateral collateral ligament). The overall limb alignment is assessed by comparing the Hip-Knee-Ankle angle from pre-operative to 1-year post-operative on a long leg weight bearing x-ray.

    Time frame: Pre-operative (2 weeks prior to surgery), intra-operative, Post-operative - 6 weeks, 12 months and 24 months

07

Study locations

1 site
  • North Shore Hospital
    Takapuna, Auckland 0622, New Zealand
08

References and documents

Publications

  • Young SW, Zeng N, Tay ML, Fulker D, Esposito C, Carter M, Bayan A, Farrington B, Van Rooyen R, Walker M. A prospective randomised controlled trial of mechanical axis with soft tissue release balancing vs functional alignment with bony resection balancing in total knee replacement-a study using Stryker Mako robotic arm-assisted technology. Trials. 2022 Jul 20;23(1):580. doi: 10.1186/s13063-022-06494-4. PubMed 35858944 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 23, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04600583
Lead sponsor
Stryker South Pacific
Responsible party
Sponsor
First posted
Oct 23, 2020
Start date
Nov 12, 2020
Primary completion
Dec 20, 2023
Completion
Mar 2025 (estimated)
Last update
Jul 23, 2024

Study contacts

Simon Young, Dr
principal investigator · North Shore Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion